<DOC>
	<DOCNO>NCT01110941</DOCNO>
	<brief_summary>S-1 oral fluoropyrimidine demonstrate efficacy gastric cancer colorectal cancer . The new regimen Oxaliplatin leucovorin expect achieve encouraging efficacy colorectal cancer . This study explore feasibility SOL regimen efficacy tolerability Chinese colorectal cancer patient .</brief_summary>
	<brief_title>Feasibility Study SOL ( S-1 , Oral Leucovorin , Oxaliplatin ) Colorectal Cancer China</brief_title>
	<detailed_description>- Endpoints : - Primary endpoint : adverse drug reaction - Secondary endpoint : - Overall Response Rate：ORR - Progress Free Survival : PFS - Time Treatment Failure：TTF</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Advanced unresectable recurrent colorectal cancer patient meet follow criterion : Willing sign ICF Could orally take investigational product Pathology diagnosis adenocarcinoma Above 20 year No previous treatment ( include : radiotherapy , chemotherapy immunotherapy ) For recurrent case , patient receive adjuvant chemotherapy n't include S1 LOHP 180 day ago , he/she could enrol With target lesion diameter longer 1cm spiral CT MRI examination within 30 day Lab test within 15 day meet follow criterion Hemoglobin high 9.0g/dL Leukocyte high 12,000/mm3 Neutrophil high 2,000/mm3 PLT high 10.0 104/mm3 Bilirubin low 1.5 time upper limit normal range AST , ALT , ALP low 2.5 time upper limit normal range Creatinine low upper limit normal range When patient liver metastasis bone metastasis , value AST , ALT , ALP could within 5 time upper limit normal range ECOG 0 1 Expected survival time 90 day The patient meet follow criterion exclude trial Patients severe drug allergic history ( include : platinum related drugs,5FU , FT , LV,5HT3 receptor antagonist ) Attended clinical trial within 4 week Received transfusion blood , related product GCSF within 15 day Received surgery within 4 week effect n't vanish Have diarrhea Have complication active infection ( infection cause fever high 38℃ ) Have complication poor control hypercalcemia , hypertension , diabetes Have complication severe ECG abnormal heart disease affect clinical treatment ( include : cardiac dysfunction , myocardial infarction , angina ) Have complication severe pulmonary disease ( include : interstitial pneumonia , pulmonary fibrosis , severe emphysema ) Have complication psychiatric disorder affect clinical treatment history CNS disease Have complication active gastrointestinal bleeding Have pleural effusion , ascites pericardial effusion need drainage Have complication multiple bone metastasis Have severe complication ( include : ileus , renal insufficiency , hepatic insufficiency , cerebrovascular disturbance ) Have brain metastasis suspicious brain metastasis Have active multiple primary cancer Female patient pregnancy lactation patient willing take contraception measure Investigator judge eligible trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>S-1</keyword>
	<keyword>leucovorin</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>SOL</keyword>
	<keyword>unresectable recurrent colorectal cancer</keyword>
</DOC>